#189 Bisphosphonates and Fracture Prevention Trial: Beyond Journal Club with NEJM Group

#189 Bisphosphonates and Fracture Prevention Trial: Beyond Journal Club with NEJM Group

Who’s really at risk for fractures, and how should we be treating them?

Most fragility fractures occur in patients without osteoporosis. Should we rethink who gets treated? And could just one or two IV infusions (spread years apart) of zoledronate prevent fractures for years? Have the concerns about bisphosphonates been overblown?

Find out all the nuances on this episode of Beyond Journal Club, a series brought to you by Core IM in collaboration with NEJM Group.


🔹 Sponsor: Oakstone CME

Use the code "CORE25" for 25% off: https://www.coreimpodcast.com/MKSAP

🔹 Transcript & Show Notes

Timestamps:

(00:59) | Diagnosing Osteoporosis and Hidden Fracture Risk

(05:38) | Evolution of Bisphosphonate Use in Osteoporosis Treatment

(07:51) | Current Use of Bisphosphonates: Benefits, Risks, and Side Effects

(10:31) | Exploring Non-Bisphosphonate Options for Fracture Prevention

(11:44) | Teriparatide and Alternative Osteoporosis Medications

(14:53) | Inside the Latest Bisphosphonate Clinical Trial

(18:07) | Key Findings from the Zoledronate Fracture Prevention Study

(22:38) | Public Health Impact of Fracture Prevention Strategies

(24:24) | Final Takeaways and Expert Perspectives on Osteoporosis Care


Tags: CoreIM, Internal Medicine, Primary Care, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student, Osteoporosis, Fragility Fractures, Zoledronate, Bone Health



Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

Jaksot(212)

#180 Beta-Blockers & REDUCE-AMI Trial: Beyond Journal Club Segment with NEJM Group

#180 Beta-Blockers & REDUCE-AMI Trial: Beyond Journal Club Segment with NEJM Group

How much do beta blockers help after a heart attack, even when the heart’s pumping well? In this episode, we revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and exp...

25 Kesä 202526min

#179 Invasive Fungal Disease: 5 Pearls Segment

#179 Invasive Fungal Disease: 5 Pearls Segment

🔹 What is invasive fungal disease, and who is most at risk for developing invasive fungal disease? (~ 02:46)🔹 What are the main classes of fungi? (~11:35)🔹 What are the pros and cons of B-D Glucan ...

11 Kesä 202545min

#178 Continuous Glucose Monitor (CGM): 5 Pearls Segment

#178 Continuous Glucose Monitor (CGM): 5 Pearls Segment

🔹What are clinically relevant limitations of an A1c vs. a CGM (1:40)🔹What do the different parts of the ambulatory glucose profile tell you? (09:59)🔹What are common pitfalls, medications, lifestyle...

2 Kesä 202533min

#177 Interventional Radiology (IR) 101: 5 Pearls Segment

#177 Interventional Radiology (IR) 101: 5 Pearls Segment

🔹When is an U/S vs. CT vs. MRI helpful before consulting Interventional Radiology?🔹What factors go into an IR pre-op evaluation?🔹 When do drains go in, and when do they come out?🔹 When a patient h...

14 Touko 202543min

#176 Constipation Medications: 5 Pearls Segment

#176 Constipation Medications: 5 Pearls Segment

🔹 High-yield reversible causes of constipation? (02:26)🔹 Which type of fiber is more helpful? And is more hydration really better? And bulk-forming laxatives (9:03)🔹 Osmotic vs Stimulant Laxatives ...

30 Huhti 202539min

#175 A Revolution in HIV Prevention & The PURPOSE Trials: Beyond Journal Club Segment with NEJM Group

#175 A Revolution in HIV Prevention & The PURPOSE Trials: Beyond Journal Club Segment with NEJM Group

How good are we at preventing HIV? How do efficacy and effectiveness differ? We journey from oral pre-exposure prophylaxis (PrEP) to long-acting injectables, and then to the PURPOSE trials, which look...

16 Huhti 202527min

#174 Lp(a) and ASCVD Risk: 5 Pearls Segment

#174 Lp(a) and ASCVD Risk: 5 Pearls Segment

What does Lipoprotein(a) tell us that a standard lipid panel doesn’t? Should we be testing everyone for it? Dive into the genetics, clinical implications, and evolving management strategies for Lp(a)....

2 Huhti 202543min

#173 Hypercoagulability Workup: 5 Pearls Segment

#173 Hypercoagulability Workup: 5 Pearls Segment

A new way to think of clots beyond provoked vs. unprovoked: Learn all about how important it is to think about reversibility! What patient states affect the inherited thrombophilia testing? Learn the ...

19 Maalis 202544min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
rss-liian-kuuma-peruna
adhd-podi
rss-eron-alkemiaa
rahapuhetta
aamukahvilla
kesken
rss-duodecim-lehti
rss-koira-haudattuna
psykologia
rss-tietoinen-yhteys-podcast-2
rss-vapaudu-voimaasi
rss-finnish-daily-dialogues
rss-niinku-asia-on
rss-onks-ok
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta